Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-013838
Filing Date
2019-04-30
Accepted
2019-04-29 18:45:57
Documents
4
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A rkda-defa14a_20181231.htm DEFA14A 40787
2 GRAPHIC gs4f0vv5mhqc000001.jpg GRAPHIC 33405
3 GRAPHIC gs4f0vv5mhqc000003.jpg GRAPHIC 24543
4 GRAPHIC gs4f0vv5mhqc000002.jpg GRAPHIC 52860
  Complete submission text file 0001564590-19-013838.txt   194827
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37383 | Film No.: 19777709
SIC: 2870 Agricultural Chemicals